Cellophane maculopathy
Cellophane maculopathy is a medical condition that affects the eye's macula, the part of the retina responsible for central, high-resolution vision. It is also known as macular pucker or epiretinal membrane.
Overview[edit | edit source]
Cellophane maculopathy is characterized by the formation of a thin, semi-transparent layer of fibrous tissue over the macula. This layer, which resembles cellophane, can cause distortion and blurring of central vision. The condition is most commonly seen in individuals over the age of 50, but can occur at any age.
Causes[edit | edit source]
The exact cause of cellophane maculopathy is unknown, but it is believed to be associated with changes in the vitreous, the gel-like substance that fills the eye. As the vitreous shrinks and pulls away from the retina, it can cause damage that leads to the formation of the cellophane-like membrane. Other potential causes include eye injury, retinal detachment, retinal tear, and inflammatory eye diseases.
Symptoms[edit | edit source]
Symptoms of cellophane maculopathy can vary in severity, but often include blurred or distorted vision, difficulty reading, and seeing straight lines as wavy or distorted. Some individuals may also experience a decrease in color perception.
Diagnosis[edit | edit source]
Cellophane maculopathy is typically diagnosed through a comprehensive eye examination. This may include a visual acuity test, a dilated eye exam, and imaging tests such as optical coherence tomography (OCT) and fluorescein angiography.
Treatment[edit | edit source]
Treatment for cellophane maculopathy is typically only recommended if the condition is causing significant vision problems. Options may include vitrectomy, a surgical procedure to remove the vitreous and the cellophane-like membrane, and membrane peeling, a procedure to remove the membrane from the surface of the retina.
Prognosis[edit | edit source]
The prognosis for cellophane maculopathy is generally good, with many individuals experiencing an improvement in vision following treatment. However, some may continue to experience mild distortion or blurring of vision.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD